CFDE Data Portal | Search SLC30A2

	Label	Description
	SLC30A2 associations Collection (Entity type)	Associations for SLC30A2_associations
	SLC30A2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	SLC30A2 Gene (Entity type)	ENSG00000158014 - solute carrier family 30 member 2
	GSE216988 GSE216989 decitabine 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE125862 2 V 1 DEXAMETHASONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE192771 2 V 3 SORAFENIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE210655 1 V 0 CISPLATIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE172458 0 V 1 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE218580 1 V 4 FENTANYL MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE182680,GSE182683 7 V 13 DEXAMETHASONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

SLC30A2 associations

Associations for SLC30A2_associations

SLC30A2 associations.tsv

A file from IDG as part of the Harmonizome project

SLC30A2

ENSG00000158014 - solute carrier family 30 member 2

GSE216988 GSE216989 decitabine 0 v 1 human up

A Gene Set from LINCS

GSE125862 2 V 1 DEXAMETHASONE HUMAN UP

A Gene Set from LINCS

GSE192771 2 V 3 SORAFENIB HUMAN UP

A Gene Set from LINCS

GSE210655 1 V 0 CISPLATIN MOUSE UP

A Gene Set from LINCS

GSE172458 0 V 1 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE218580 1 V 4 FENTANYL MOUSE DN

A Gene Set from LINCS

GSE182680,GSE182683 7 V 13 DEXAMETHASONE HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.